Genmab | GEN - Actif À Court Terme

Prix De L'Action
1,758.50
Variation Quotidienne
-11.00 -0.62%
Mensuellement
-1.68%
Annuel
36.32%
Q2 Prévisions
1,613.20




Actif À Court Terme Changement Date
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Almirall EUR 713.98M 69K 2025-12
Amarin USD 626.02M 23.87M 2026-03
Amgen USD 31.48B 2.42B 2026-03
argenx SE USD 6.9B 1.07B 2025-12
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 32.91B 30M 2025-12
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Demant DKK 10.08B 128M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Fresenius Medical Care EUR 7.9B 74M 2025-12
Galapagos EUR 3.08B 82.56M 2025-12
Genmab DKK 2.88B 1.59B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
GN Store Nord DKK 4.85B 3.79B 2026-03
GRIFOLS EUR 5.07B 274.77M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Insmed USD 1.61B 181.04M 2026-03
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.23B 354M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
UCB EUR 6.05B 733M 2025-12